These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN. Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [Abstract] [Full Text] [Related]
5. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Rocca PC, Brunelli M, Gobbo S, Eccher A, Bragantini E, Mina MM, Ficarra V, Zattoni F, Zamò A, Pea M, Scarpa A, Chilosi M, Menestrina F, Bonetti F, Eble JN, Martignoni G. Mod Pathol; 2007 Jul; 20(7):722-8. PubMed ID: 17483815 [Abstract] [Full Text] [Related]
6. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Kuroda N, Tanaka A, Yamaguchi T, Kasahara K, Naruse K, Yamada Y, Hatanaka K, Shinohara N, Nagashima Y, Mikami S, Oya M, Hamashima T, Michal M, Hes O. Med Mol Morphol; 2013 Mar; 46(1):49-55. PubMed ID: 23338778 [Abstract] [Full Text] [Related]
7. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma. Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A. Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843 [Abstract] [Full Text] [Related]
8. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma. Kim SS, Choi YD, Jin XM, Cho YM, Jang JJ, Juhng SW, Choi C. Histopathology; 2009 Apr; 54(5):633-5. PubMed ID: 19302533 [No Abstract] [Full Text] [Related]
9. Categorizing renal oncocytic neoplasms on core needle biopsy: a morphologic and immunophenotypic study of 144 cases with clinical follow-up. Alderman MA, Daignault S, Wolf JS, Palapattu GS, Weizer AZ, Hafez KS, Kunju LP, Wu AJ. Hum Pathol; 2016 Sep; 55():1-10. PubMed ID: 27085554 [Abstract] [Full Text] [Related]
10. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Li G, Barthelemy A, Feng G, Gentil-Perret A, Peoc'h M, Genin C, Tostain J. Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501 [Abstract] [Full Text] [Related]
11. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Huang W, Kanehira K, Drew S, Pier T. Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342 [Abstract] [Full Text] [Related]
12. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Carvalho JC, Wasco MJ, Kunju LP, Thomas DG, Shah RB. Histopathology; 2011 Jan; 58(2):169-79. PubMed ID: 21323945 [Abstract] [Full Text] [Related]
13. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. Choi YD, Kim KS, Ryu S, Park Y, Cho NH, Rha SH, Jang JJ, Ro JY, Juhng SW, Choi C. J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941 [Abstract] [Full Text] [Related]
14. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma. Kuroda N, Guo L, Toi M, Naruse K, Miyazaki E, Hayashi Y, Yoshikawa C, Ashida S, Shuin T, Enzan H. Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057 [Abstract] [Full Text] [Related]
15. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Wang HY, Mills SE. Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088 [Abstract] [Full Text] [Related]
16. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Geramizadeh B, Ravanshad M, Rahsaz M. Indian J Pathol Microbiol; 2008 May; 51(2):167-71. PubMed ID: 18603673 [Abstract] [Full Text] [Related]
17. Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms. Mannan R, Wang X, Bawa PS, Zhang Y, Skala SL, Chinnaiyan AK, Dagar A, Wang L, Zelenka-Wang SB, McMurry LM, Daniel N, Cao X, Sangoi AR, Gupta S, Vaishampayan UN, Hafez KS, Morgan TM, Spratt DE, Tretiakova MS, Argani P, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Int J Surg Pathol; 2023 Sep; 31(6):1027-1040. PubMed ID: 36250542 [Abstract] [Full Text] [Related]
18. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Osunkoya AO, Cohen C, Lawson D, Picken MM, Amin MB, Young AN. Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195 [Abstract] [Full Text] [Related]
19. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies. Conner JR, Hirsch MS, Jo VY. Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652 [Abstract] [Full Text] [Related]
20. p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. Head Neck Pathol; 2007 Dec; 1(2):123-31. PubMed ID: 20614263 [Abstract] [Full Text] [Related] Page: [Next] [New Search]